Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles Made From Novel Starch Derivatives For Transdermal Drug Delivery.

M. J. Santander-Ortega, T. Stauner, B. Loretz, J. L. Ortega-Vinuesa, D. Bastos-González, G. Wenz, U. Schäfer, C. Lehr
Published 2010 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The goal of this paper was aimed to the formulation of nanoparticles by using two different propyl-starch derivatives - referred to as PS-1 and PS-1.45 - with high degrees of substitution: 1.05 and 1.45 respectively. A simple o/w emulsion diffusion technique, avoiding the use of hazardous solvents such as dichloromethane or dimethyl sulfoxide, was chosen to formulate nanoparticles with both polymers, producing the PS-1 and PS-1.45 nanoparticles. Once the nanoparticles were prepared, a deep physicochemical characterization was carried out, including the evaluation of nanoparticles stability and applicability for lyophilization. Depending on this information, rules on the formation of PS-1 and PS-1.45 nanoparticles could be developed. Encapsulation and release properties of these nanoparticles were studied, showing high encapsulation efficiency for three tested drugs (flufenamic acid, testosterone and caffeine); in addition a close to linear release profile was observed for hydrophobic drugs with a null initial burst effect. Finally, the potential use of these nanoparticles as transdermal drug delivery systems was also tested, displaying a clear enhancer effect for flufenamic acid.
This paper references
10.1023/A:1015810312465
Predicting Skin Permeability
R. Potts (2004)
10.1016/J.EJPB.2004.02.016
Polysaccharide-decorated nanoparticles.
C. Lemarchand (2004)
10.1016/S0168-3659(97)00106-5
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
M. Zambaux (1998)
10.1016/J.ADDR.2006.09.007
Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems.
D. Y. Arifin (2006)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1002/JBM.820290610
Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG.
E. Osterberg (1995)
10.1016/S0006-3495(96)79407-9
Is trehalose special for preserving dry biomaterials?
L. Crowe (1996)
10.1016/J.BIOMATERIALS.2003.09.093
Enzymatic degradation of starch-based thermoplastic compounds used in protheses: identification of the degradation products in solution.
M. A. Araújo (2004)
10.1016/J.ADDR.2006.09.017
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
10.1021/MA021132A
Polysaccharides Grafted with Polyesters: Novel Amphiphilic Copolymers for Biomedical Applications
R. Gref (2002)
10.1201/9781420009774.ch5
Percutaneous Penetration Enhancers
E. W. Smith (1995)
10.1111/J.0022-202X.2004.22717.X
Penetration profile of microspheres in follicular targeting of terminal hair follicles.
R. Toll (2004)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/J.COLSURFB.2007.06.002
Electrophoretic mobility and colloidal stability of PLGA particles coated with IgG.
M. J. Santander-Ortega (2007)
10.1023/A:1025017502379
Novel Polyester-Polysaccharide Nanoparticles
C. Lemarchand (2004)
10.1016/J.CARBPOL.2006.12.007
Nanoscale structures of dextran esters
S. Hornig (2007)
10.1093/AJCP/110.4.425
Alpha-L-fucose: a potentially critical molecule in pathologic processes including neoplasia.
J. Listinsky (1998)
10.3109/02652049809006840
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique.
D. Quintanar-Guerrero (1998)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1002/CPHC.200600521
Hofmeister effects on poly(NIPAM) microgel particles: macroscopic evidence of ion adsorption and changes in water structure.
T. López-León (2007)
10.1016/J.COLSURFA.2006.09.036
Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: A comparative study
M. J. Santander-Ortega (2007)
10.1016/S0014-3057(01)00306-8
Synthesis and properties of thermoplastic propyl-etherified amylose
N. Teramoto (2002)
10.1016/J.ADDR.2003.10.028
Lipid vesicles and other colloids as drug carriers on the skin.
G. Cevc (2004)
10.1023/A:1021497625645
Protective Mechanism of Stabilizing Excipients Against Dehydration in the Freeze-Drying of Proteins
Y. Liao (2004)
10.1016/0168-3659(93)90103-C
The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery
P. Scholes (1993)
10.1177/026119290603400312
Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study
M. Schäfer-Korting (2006)
Comprar Colloid Stability: The Role of Surface Forces, Part II, Volume 2 | Tharwat F. Tadros | 9783527315031 | Wiley
T. Tadros (2007)
10.1016/S0168-3659(03)00259-1
Drug release from starch-acetate films.
L. Tuovinen (2003)
10.1021/JP063134T
Glass transition temperature of glucose, sucrose, and trehalose: an experimental and in silico study.
Alexandra Simperler (2006)
10.1016/S0168-3659(03)00296-7
Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins.
J. Rodrigues (2003)
10.1016/S0378-5173(03)00380-6
Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery.
M. Sameti (2003)
10.1159/000093114
Influence of Nanoencapsulation on Human Skin Transport of Flufenamic Acid
J. Luengo (2006)
10.1021/LA981445S
How Proteins Stabilize Colloidal Particles by Means of Hydration Forces
J. Molina-Bolívar (1999)
10.1016/S0142-9612(01)00272-1
The biocompatibility of novel starch-based polymers and composites: in vitro studies.
A. P. Marques (2002)
10.1016/J.JCONREL.2004.05.016
Starch acetate microparticles for drug delivery into retinal pigment epithelium-in vitro study.
L. Tuovinen (2004)
10.1016/0032-3861(96)87626-9
Physical properties of acetylated starch-based materials: Relation with their molecular characteristics
C. Fringant (1996)
10.1016/S0928-0987(98)00066-9
Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
M. Chacón (1999)
10.1016/J.JCONREL.2004.06.015
Skin penetration and distribution of polymeric nanoparticles.
R. Alvarez-Román (2004)
10.1016/S0168-3659(02)00127-X
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
S. Sahoo (2002)
10.22028/D291-22373
Human skin drug delivery using biodegradable PLGA-nanoparticles
Luengo Contreras (2007)
10.1002/APP.20851
Characterization of crosslinked starch materials with spectroscopic techniques
Franck Delval (2004)
10.1007/S00449-007-0112-5
Hydrophobic grafted and cross-linked starch nanoparticles for drug delivery
C. K. Simi (2007)
10.1023/B:PHAM.0000045235.86197.ef
Enhancement of Topical Delivery from Biodegradable Nanoparticles
Rocx00EDo Alvarez-Romx00E1n (2004)
10.1016/J.JCIS.2006.07.031
Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
M. J. Santander-Ortega (2006)



This paper is referenced by
10.4028/www.scientific.net/JNanoR.56.131
Size Controlled Preparation of Starch Nanoparticles from Wheat through Precipitation at Low Temperature
Behnaz Momenpoor (2019)
10.1007/s10965-019-1770-0
Effects of amylose content on starch-chitosan composite film and its application as a wound dressing
Wen-Ching Wu (2019)
10.1007/s00396-012-2669-z
Chitosan-based nanocapsules: physical characterization, stability in biological media and capsaicin encapsulation
F. Goycoolea (2012)
10.1007/978-3-319-41129-3
Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae
Saurabh Bhatia (2016)
10.3390/nano7050110
Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro
Zhuo Wu (2017)
Modified Starch as a Versatile Pharmaceutical Excipient : A Comprehensive
U. Kandekar (2019)
10.1016/j.colsurfb.2010.10.019
Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability.
M. J. Santander-Ortega (2011)
10.1007/978-3-319-12478-0_2
Biodegradable Natural Polymers
Sindhu Doppalapudi (2015)
10.1016/B978-0-12-809740-3.00008-8
Nanoencapsulation of Enzymes, Bioactive Peptides, and Biological Molecules
M. Y. Çağlar (2017)
10.1016/j.biomaterials.2016.10.045
Rapid and efficient crossing blood-brain barrier: Hydrophobic drug delivery system based on propionylated amylose helix nanoclusters.
W. Gao (2017)
10.5772/51384
Nanotechnology in Drug Delivery
M. Emeje (2012)
10.3109/03639045.2012.756511
Preparation of novel porous starch microsphere foam for loading and release of poorly water soluble drug
T. Jiang (2014)
10.1007/978-3-319-41129-3_4
Plant Derived Polymers, Properties, Modification & Applications
Saurabh Bhatia (2016)
10.1016/j.ejpb.2016.10.019
Poly[acrylonitrile‐co‐(N‐vinyl pyrrolidone)] nanoparticles – Composition‐dependent skin penetration enhancement of a dye probe and biocompatibility
N. Zhang (2017)
10.1016/j.carbpol.2012.07.025
The effect of NaCl on the rheological properties of suspension containing spray dried starch nanoparticles.
Ai-min Shi (2012)
10.1016/j.carbpol.2012.07.059
Rheological properties of suspensions containing cross-linked starch nanoparticles prepared by spray and vacuum freeze drying methods.
A. Shi (2012)
10.1002/STAR.201600105
Human monocyte response to Andean‐native starch nanoparticles
F. Gatto (2016)
10.1002/mds3.10111
Non‐conventional starch nanoparticles for drug delivery applications
O. P. Troncoso (2020)
10.1002/jbm.a.34350
Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery.
W. Lv (2013)
10.1016/j.ultsonch.2017.07.033
Ultrasonic-assisted fabrication of starch/MWCNT-glucose nanocomposites for drug delivery.
S. Mallakpour (2018)
10.1002/jsfa.9918
Citric-Acid Modified Banana Starch Nanoparticles as a Novel Vehicle for β-Carotene Delivery.
Daniela Santoyo-Aleman (2019)
10.1016/j.ijbiomac.2014.12.012
A systematic evaluation of hydroxyethyl starch as a potential nanocarrier for parenteral drug delivery.
D. Narayanan (2015)
10.1016/j.addr.2011.01.012
Nanoparticles and microparticles for skin drug delivery.
T. Prow (2011)
Nanosistemas para el tratamiento de la diabetes mellitus por vía transmucosal
Angela Valle Gallego (2011)
10.1039/C6TB00178E
Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins.
S. Barthold (2016)
10.1002/9783527683772.CH8
Bio‐based Nanomaterials and Their Bionanocomposites
Dipali R. Bagal-Kestwal (2016)
10.2147/RRTD.S32621
Nanocarriers for transdermal drug delivery
José Juan Escobar-Chávez (2012)
10.1142/s1793292019501455
Release Mechanism and pH Responsiveness of Starch-Based Polymers
Zongliang Kou (2019)
10.1016/j.ijpharm.2015.05.050
Topical and transdermal delivery of caffeine.
L. Luo (2015)
10.1016/j.msec.2020.111242
Design of dialdehyde cellulose crosslinked poly(vinyl alcohol) hydrogels for transdermal drug delivery and wound dressings.
Monika Muchová (2020)
10.1002/star.201900175
Preparation of Photo‐Crosslinking Starch Colloidal Particles
Rongli Zhang (2020)
Effects of synthesis parameters on drug loading capacity of starch nanoparticles
Chong Chun Ling Doris (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar